10 years survival of the cemented and uncemented total hip arthroplasty

10 years survival of the cemented and uncemented Anatomic Benoist Girard (ABG) total hip arthroplasty A retrospective study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21463

Enrollment

800

Registered

2014-02-12

Start date

2014-03-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip arthrosis, coxarthrosis, destruction of the cartilage layers, Post-traumatic arthritis

Interventions

The Anatomic Benoist Girard (ABG) THA is made of a titanium alloy and has an anatomical femoral shape with only proximal fixation, the femoral component can be coated with hydroxyapatite for uncemente

Eligibility

Inclusion criteria

Inclusion criteria: o Operated between January 2000 and December 2004 o Completed the full follow up o Deceased with a known THA revision

Exclusion criteria

Exclusion criteria: o Patients who did not completed the full follow up o Deceased without a known THA revision

Design outcomes

Primary

Measure	Time frame
Comparing the initial and long-term survival of the cemented and uncemented ABG prosthesis. The primary endpoint will be defined as revision of the ABG THA for any kind. Revision for prosthesis related reasons (RPR) will be defined as revision for mechanical aseptic loosening, wear of the implant, breakage or instability due to implant failure that required surgical arthroplasty of femoral or acetabulum components.	—

Measure

Time frame

Comparing the initial and long-term survival of the cemented and uncemented ABG prosthesis. The primary endpoint will be defined as revision of the ABG THA for any kind. Revision for prosthesis related reasons (RPR) will be defined as revision for mechanical aseptic loosening, wear of the implant, breakage or instability due to implant failure that required surgical arthroplasty of femoral or acetabulum components.

—

Secondary

Measure	Time frame
Comparing the initial and long-term clinical results of the cemented and uncemented ABG prosthesis. o Standard clinical parameters (Physical examination(2.4) and Questionnaires (2.5)) will be evaluated and compared between both groups.	—

Contacts

Public ContactM.G.M. Schotanus

Department of Orthopedic Surgery, Orbis Medisch Centrum dr H vd Hoffplein 1

m.schotanus@zuyderland.nl+31 (0)88 4597823

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)